ClearPoint Neuro, Inc. (Nasdaq:CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, announces that it has completed its previously announced acquisition of IRRAS Holdings, Inc. (“IRRAS”). Under the terms of the merger agreement previously announced, the Company paid $5.0 million in cash and issued 1,325,000 shares of its common stock to IRRAS shareholders. The acquisition brings to the Company the novel IRRAflow active fluid-exchange system, a differentiated technology designed to modernize the management of intracranial bleeding.
Read the full article: ClearPoint Neuro Completes Acquisition of IRRAS //
Source: https://www.accessnewswire.com/newsroom/en/biotechnology/clearpoint-neuro-completes-acquisition-of-irras-1105470